CVS Well being Corp Earnings Report: Is it a Beat?
CVS Well being Corp (CVS) reported an earnings beat for its 4th quarter, ending 12/31/2022. Earnings per share got here in at $1.99, versus the anticipated $1.92.
The reported income of $83.88 billion represents development of three.22% in comparison with the earlier quarter, and development of 9.70% in comparison with the identical interval final yr.
For the 1st quarter, analysts venture earnings of $2.22 per share.
Usually, earnings bulletins have an effect on a inventory’s worth. See a historical past of earnings-related worth modifications for CVS inventory.
What’s Subsequent for CVS Well being Corp, Submit-Earnings?
In line with TipRanks, the common analyst consensus on CVS inventory is a Robust Purchase. This consensus relies on 9 analyst scores made previously 3 months. CVS Well being Corp’s common worth goal of $116.25 implies upside potential of 30.68% from present ranges.
See our Earnings Calendar for a full listing of this week’s earnings releases.
Backside Line
An earnings beat can signify constructive motion forward for a inventory’s worth. At the moment, CVS worth is $88.96, indicating a 5-day rise of three.72%.
About CVS Well being Corp
Headquartered in Rhode Island and based in 1963, CVS Well being Corp. is a healthcare firm within the U.S. that owns CVS Pharmacy, a retail pharmacy chain; CVS Caremark, a pharmacy advantages supervisor; Aetna, a medical insurance supplier, amongst many different manufacturers..
Be taught extra about CVS financials right here
